ifmagic glp-1 Compounded GLP-1s: Why doctors worry and the FDA is cracking down GLP-1 and Anesthesia: Considerations and

however, they have important limitations in achieving sustainable long-term weight loss

Learn about Tresiba (insulin degludec), a once-daily, long-acting basal insulin for patients over 1 year of age with type 1 or type 2 diabetes

Objective This systematic review aims to synthesise published evidence on respiratory adverse events temporally associated with GLP-1 RA therapy in adults, characterise their patterns and severity, appraise the risk of bias using validated design-appropriate tools, describe proposed pathophysiological mechanisms, and grade the certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework

A recent review in Diabetes Care evaluates the efficacy and safety of GLP-1 receptor agonists for type 2 diabetes and obesity, exploring their potential for new medical indications.

Nausea is one of the most common and uncomfortable side effects of GLP-1 therapy